Agonist actions of dihydroergotamine at 5-HT(2B) and 5-HT(2C) receptors and their possible relevance to antimigraine efficacy

1. The pharmaceutical compound, dihydroergotamine (DHE) is dispensed to prevent and reduce the occurrence of migraine attacks. Although still controversial, the prophylactic effect of this drug is believed to be caused through blockade and/or activation of numerous receptors including serotonin (5-H...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Schaerlinger, B, Hickel, P, Etienne, N, Guesnier, L, Maroteaux, L
Formato: Artigo
Idioma:Inglês
Publicado: 2003
Assuntos:
Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1574033/
https://ncbi.nlm.nih.gov/pubmed/12970106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705437
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares